Deschloroketamine (DCK) Pellets 20mg compressed arylcyclohexylamine research material
DeschcloroKetamine (DCK) Pellets - 20mg Price range: € 19,75 through € 537,50
Back to products
MXP (Methoxphenidine) Crystal research chemical in crystalline form
MXP (Methoxphenidine) Crystal Price range: € 22,00 through € 80,00

3-Me-PCPy Powder

Price range: € 60,00 through € 125,00

3-Me-PCPy Powder is described as a fine crystalline research material associated with 3-methylrolicyclidine, a methyl-substituted arylcyclohexylamine structurally related to phencyclidine derivatives.

The supplied specifications identify the material as white to off-white powder in nominal 1 g portions.

The source reports CAS number 1622348-63-3, molecular formula C17H25N, and molecular weight 243.39 g/mol.

These molecular specifications are internally consistent within rounding, although the CAS assignment and physical sample identity have not been independently verified.

The product brief claims at least 98% ingredient purity by HPLC, supported by additional chromatographic and spectroscopic testing.

It also reports particle-size specifications, residual-solvent limits, heavy-metal limits, and batch traceability.

No batch-specific Certificate of Analysis or independent testing report was supplied to substantiate these claims.

Arylcyclohexylamine dissociatives may present significant neurological, behavioral, and cardiovascular hazards. The toxicological profile of this particular compound remains incompletely characterized.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12428 Category:
Description

3-Me-PCPy Powder – Research Material Information

3-Me-PCPy Powder – Product Overview

The supplied product is described as a fine crystalline research material associated with 3-methylrolicyclidine.

The compound belongs to the arylcyclohexylamine family and is structurally related to phencyclidine-derived dissociative substances.

The source specifies nominal 1 g portions in resealable packaging.

It describes laboratory contexts involving chemical identity, structural characterization, chromatographic profiling, and forensic analytical investigation.

No independently verified batch-specific analytical documentation was supplied.

The source’s claims regarding purity, particle size, and analytical performance therefore remain unverified.

Chemical Identity & Classification

The source identifies the compound as 3-methyl-PCPy, also called 3-methylrolicyclidine.

The supplied specifications are:

  • Compound designation: 3-Me-PCPy
  • Synonyms: 3-Methyl-PCPy, 3-Methylrolicyclidine
  • Reported CAS number: 1622348-63-3
  • Molecular formula: C17H25N
  • Molecular weight: Approximately 243.39 g/mol
  • Chemical class: Arylcyclohexylamine
  • Product form: Fine crystalline powder
  • Nominal package size: 1 g

The supplied molecular formula corresponds to approximately 243.39 g/mol, consistent with the reported molecular weight.

This arithmetic agreement does not independently establish the identity or purity of a physical sample.

The CAS assignment and structural identity should be checked against authoritative records and batch-specific analytical evidence.

Public chemical-reference information can be reviewed through PubChem.

Chemical & Physical Characteristics

The source describes white to off-white fine crystalline powder.

No independently verified appearance, melting point, crystal-form analysis, or thermal-stability dataset was supplied.

The brief reports solubility of approximately 10 mg/mL in DMSO or ethanol.

No supporting solubility measurement, test temperature, or experimental method was provided.

The source also claims a particle-size distribution with D90 below 50 micrometers.

That claim remains unverified.

Particle size can affect material handling and dissolution behavior, but a reported particle-size specification does not independently establish quantitative analytical recovery.

Purity & Analytical Verification

The source reports a typical ingredient purity of at least 98% by HPLC.

It additionally refers to HPLC area purity above 98.5%, GC-MS, proton NMR, carbon-13 NMR, and high-resolution mass spectrometry.

No chromatograms, spectra, impurity profiles, or batch-specific Certificate of Analysis were provided.

The reported purity and identity-confirmation claims therefore remain unverified.

The supplied molecular formula C17H25N is consistent with a neutral monoisotopic molecular mass of approximately 243.1987 Da.

A protonated molecular ion would consequently be expected near m/z 244.2060.

The source’s nominal [M+H]+ value of m/z 244 is consistent with this calculation, but a matching mass alone does not establish structural identity.

No certified reference-material status or validated analytical performance has been demonstrated.

Quality Control & Batch Integrity

The brief claims traceability from synthesis through recrystallization and final verification.

It also describes third-party laboratory testing for residual solvents and heavy metals.

The stated limits are below 5,000 ppm for residual solvents and below 15 ppm for heavy metals.

No supporting analytical reports or specifications identifying individual solvent or elemental analytes were supplied.

The source also claims a D90 particle-size value below 50 micrometers.

No particle-size distribution report was provided.

These quality-control statements should be treated as unverified supplier claims.

The source’s synthesis-related statement does not independently establish the manufacturing history or identity of the finished material.

Safety, Handling & Laboratory Precautions

3-Methylrolicyclidine is associated with the arylcyclohexylamine dissociative class.

The toxicological profile of this specific compound is incompletely characterized.

Potential concerns associated with dissociative arylcyclohexylamines include impaired coordination, confusion, altered perception, agitation, and cardiovascular complications.

Laboratories should use institutional chemical-safety procedures appropriate for incompletely characterized psychoactive substances.

These procedures should address restricted access, suitable protective equipment, contamination prevention, accidental-exposure response, secure custody, and chemical-waste management.

No verified product-specific Safety Data Sheet was supplied.

No human or veterinary use is established or endorsed.

Packaging, Labeling & Storage

The source describes nominal 1 g portions supplied in resealable inert packaging.

It recommends storage at approximately -20°C, protected from light and moisture.

No validated product-specific stability study was supplied to establish the necessity or suitability of this temperature.

No verified shelf life, packaging-barrier specification, or long-term stability dataset was provided.

Laboratory inventory records should distinguish supplier-reported specifications from batch-verified measurements.

Intended Research Use & Market Positioning

The source describes analytical laboratory contexts involving arylcyclohexylamine characterization, chromatographic comparison, spectroscopic identification, and forensic chemical analysis.

No certified reference-material status or validated quantitative calibration performance has been demonstrated.

The supplied Raw Lab Chems catalog references are:

These references concern related but chemically distinct arylcyclohexylamines.

They should not be represented as interchangeable compounds or analytically equivalent materials.

Ordering, Availability & Fulfillment

The source claims worldwide shipping, tracking, customs documentation, protective packaging, and compliance with IATA and DOT requirements.

No current inventory record, transport classification, carrier authorization, or supporting shipping documentation was provided.

These claims cannot be independently confirmed.

Research-only labeling does not automatically exempt a psychoactive substance from controlled-substance legislation, analogue laws, or import restrictions.

Transport eligibility and legal authorization depend on the applicable jurisdiction and transaction.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

3-Me-PCPy is a psychoactive arylcyclohexylamine-related substance that may be subject to controlled-substance, analogue, chemical-safety, import, or export restrictions.

Institutions are responsible for verifying applicable legal requirements and maintaining appropriate authorization, laboratory controls, and secure custody.

No therapeutic approval, consumer-use authorization, or certified reference-material status is implied.

Additional information
Quantity (0.5 grams)

2

,

5

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “3-Me-PCPy Powder”
Shipping & Delivery